These findings not only emphasize the ability of ROMO1 to regulate monocyte function in RA, MS, and T1D, but also reveal that there may be a complex mechanism of interaction between ROMO1 and monocyte. This evidence concerns the gene ROMO1 and type 1 diabetes mellitus.